Hemostatic issues in pregnancy-induced liver disease.

[1]  R. Porte,et al.  Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management. , 2017, Anesthesiology.

[2]  A. Sanyal,et al.  Preserved hemostatic status in patients with non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[3]  R. Porte,et al.  Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen , 2016, Journal of thrombosis and haemostasis : JTH.

[4]  E. Lockhart.  Postpartum hemorrhage: a continuing challenge. , 2015, Hematology. American Society of Hematology. Education Program.

[5]  D Katz,et al.  Disorders of coagulation in pregnancy. , 2015, British journal of anaesthesia.

[6]  D. Nelson,et al.  Disseminated Intravascular Coagulation Syndromes in Obstetrics. , 2015, Obstetrics and gynecology.

[7]  W. Bernal,et al.  Management of Bleeding and Thrombosis in Critically Ill Patients with Liver Disease , 2015, Seminars in Thrombosis & Hemostasis.

[8]  A. Roy,et al.  Classical Notions of Coagulation Revisited in Relation with Blood Losses, Transfusion Rate for 700 Consecutive Liver Transplantations , 2015, Seminars in Thrombosis & Hemostasis.

[9]  R. Stravitz,et al.  Rebalanced Hemostasis in Patients with Acute Liver Failure , 2015, Seminars in Thrombosis & Hemostasis.

[10]  R. Porte,et al.  Is there a rationale for treatment of chronic liver disease with antithrombotic therapy? , 2015, Blood reviews.

[11]  R. McCarthy,et al.  The incidence of coagulopathy in pregnant patients with intrahepatic cholestasis: should we delay or avoid neuraxial analgesia? , 2014, Journal of clinical anesthesia.

[12]  D. Nelson,et al.  Hemostatic Dysfunction With Acute Fatty Liver of Pregnancy , 2014, Obstetrics and gynecology.

[13]  Michael Monsour,et al.  Incidence and Risk Factors , 2016 .

[14]  S. Caldwell,et al.  Coagulation in liver disease: a guide for the clinician. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  P. Mannucci,et al.  The coagulopathy of chronic liver disease. , 2011, The New England journal of medicine.

[16]  J. Bosch,et al.  Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension , 2011, Gut.

[17]  G. Auzinger,et al.  Outcomes of Severe Pregnancy‐Related Liver Disease: Refining the Role of Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  R. Porte,et al.  Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. , 2010, Blood.

[19]  R. Goldin,et al.  Parenchymal extinction: coagulation and hepatic fibrogenesis. , 2009, Clinics in liver disease.

[20]  L. Vatten,et al.  Abnormal bleeding associated with preeclampsia: A population study of 315,085 pregnancies , 2009, Acta obstetricia et gynecologica Scandinavica.

[21]  R. Stravitz,et al.  Coagulopathy of acute liver failure. , 2009, Clinics in liver disease.

[22]  E. Horváth-Puhó,et al.  Risk of Venous Thromboembolism in Patients With Liver Disease: A Nationwide Population-Based Case–Control Study , 2009, The American Journal of Gastroenterology.

[23]  F. Nevens,et al.  Review article: blood platelet number and function in chronic liver disease and cirrhosis , 2008, Alimentary pharmacology & therapeutics.

[24]  P. Brocklehurst,et al.  A prospective national study of acute fatty liver of pregnancy in the UK , 2008, Gut.

[25]  A. Franx,et al.  Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome , 2006, Journal of thrombosis and haemostasis : JTH.

[26]  P. D. de Groot,et al.  Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity , 2006, Hepatology.

[27]  A. Tripodi,et al.  LIVER FAILURE AND LIVER DISEASE , 2005 .

[28]  P. D. de Groot,et al.  Haemostatic abnormalities in patients with liver disease. , 2002, Journal of hepatology.

[29]  R. Williams,et al.  Maternal and perinatal outcome in severe pregnancy‐related liver disease , 1997, Hepatology.

[30]  A. Burroughs,et al.  Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. , 1997, Journal of hepatology.

[31]  P. Mannucci,et al.  High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia , 1996, Hepatology.

[32]  J. Wilson,et al.  Disseminated intravascular coagulation in liver cirrhosis. , 1992, Journal of hepatology.

[33]  J. M. Carr.  Disseminated intravascular coagulation in cirrhosis , 1989, Hepatology.

[34]  M. Steven.  Pregnancy and liver disease. , 1981, Gut.

[35]  A. Fanaroff.  A prospective national study of acute fatty liver of pregnancy in the UK , 2009 .

[36]  C. Legnani,et al.  Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation. , 1991, Haemostasis.

[37]  C. Legnani,et al.  Coagulation and Fibrinolysis in Orthotopic Liver Transplantation: Role of the Recipient’s Disease and Use of Antithrombin III Concentrates , 1991 .